{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T09:47:03Z","timestamp":1794995223147,"version":"4.9.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1038\/s41587-022-01566-x","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T12:02:56Z","timestamp":1672660976000},"page":"980-992","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["High-throughput, targeted MHC class I immunopeptidomics using a functional genetics screening platform"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-0118","authenticated-orcid":false,"given":"Peter M.","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7275-597X","authenticated-orcid":false,"given":"Richard T.","family":"Timms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouran S.","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe J. N.","family":"Lelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6690-944X","authenticated-orcid":false,"given":"Duane R.","family":"Wesemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu G.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-6283","authenticated-orcid":false,"given":"Stephen J.","family":"Elledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"key":"1566_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","volume":"125","author":"DD Chaplin","year":"2010","unstructured":"Chaplin, D. D. Overview of the immune response. J. Allergy Clin. Immunol. 125, S3\u2013S23 (2010).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1566_CR2","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0092-8674(94)90462-6","volume":"78","author":"KL Rock","year":"1994","unstructured":"Rock, K. L. et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761\u2013771 (1994).","journal-title":"Cell"},{"key":"1566_CR3","doi-asserted-by":"crossref","unstructured":"Neefjes, J., Jongsma, M. L. M., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823\u2013836 (2011).","DOI":"10.1038\/nri3084"},{"key":"1566_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.immuni.2004.07.004","volume":"21","author":"L Shen","year":"2004","unstructured":"Shen, L., Sigal, L. J., Boes, M. & Rock, K. L. Important role of cathepsin S in generating peptides for TAP-independent MHC class I crosspresentation in vivo. Immunity 21, 155\u2013165 (2004).","journal-title":"Immunity"},{"key":"1566_CR5","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","volume":"9","author":"M Embgenbroich","year":"2018","unstructured":"Embgenbroich, M. & Burgdorf, S. Current concepts of antigen cross-presentation. Front. Immunol. 9, 1643 (2018).","journal-title":"Front. Immunol."},{"key":"1566_CR6","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1182\/blood-2015-04-640532","volume":"126","author":"S Walz","year":"2015","unstructured":"Walz, S. et al. The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell-based immunotherapy. Blood 126, 1203\u20131213 (2015).","journal-title":"Blood"},{"key":"1566_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.it.2016.08.010","volume":"37","author":"KL Rock","year":"2016","unstructured":"Rock, K. L., Reits, E. & Neefjes, J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 37, 724\u2013737 (2016).","journal-title":"Trends Immunol."},{"key":"1566_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41587-019-0322-9","volume":"38","author":"S Sarkizova","year":"2020","unstructured":"Sarkizova, S. et al. A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nat. Biotechnol. 38, 199\u2013209 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1566_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/351072a0","volume":"351","author":"IF Luescher","year":"1991","unstructured":"Luescher, I. F., Romero, P., Cerottini, J. C. & Maryanski, J. L. Specific binding of antigenic peptides to cell-associated MHC class I molecules. Nature 351, 72\u201374 (1991).","journal-title":"Nature"},{"key":"1566_CR10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/eji.1830210909","volume":"21","author":"J Elvin","year":"1991","unstructured":"Elvin, J., Cerundolo, V., Elliott, T. & Townsend, A. A quantitative assay of peptide-dependent class I assembly. Eur. J. Immunol. 21, 2025\u20132031 (1991).","journal-title":"Eur. J. Immunol."},{"key":"1566_CR11","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1002\/eji.1830221033","volume":"22","author":"G Stuber","year":"1992","unstructured":"Stuber, G. et al. Assessment of major histocompatibility complex class I interaction with Epstein\u2013Barr virus and human immunodeficiency virus peptides by elevation of membrane H-2 and HLA in peptide loading-deficient cells. Eur. J. Immunol. 22, 2697\u20132703 (1992).","journal-title":"Eur. J. Immunol."},{"key":"1566_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/eji.1830230603","volume":"23","author":"HW Nijman","year":"1993","unstructured":"Nijman, H. W. et al. Identification of peptide sequences that potentially trigger HLA\u2010A2.1\u2010restricted cytotoxic T lymphocytes. Eur. J. Immunol. 23, 1215\u20131219 (1993).","journal-title":"Eur. J. Immunol."},{"key":"1566_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/340443a0","volume":"340","author":"A Townsend","year":"1989","unstructured":"Townsend, A. et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340, 443\u2013448 (1989).","journal-title":"Nature"},{"key":"1566_CR14","doi-asserted-by":"publisher","first-page":"9130","DOI":"10.1073\/pnas.90.19.9130","volume":"90","author":"MJ Androlewicz","year":"1993","unstructured":"Androlewicz, M. J., Anderson, K. S. & Cresswell, P. Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc. Natl Acad. Sci. USA 90, 9130\u20139134 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1566_CR15","doi-asserted-by":"crossref","unstructured":"Gejman, R. S. et al. Identification of the targets of T-cell receptor therapeutic agents and cells by use of a high-throughput genetic platform. Cancer Immunol. Res. 8, 672\u2013684 (2020).","DOI":"10.1158\/2326-6066.CIR-19-0745"},{"key":"1566_CR16","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/nature01074","volume":"419","author":"T Serwold","year":"2002","unstructured":"Serwold, T., Gonzalez, F., Kim, J., Jacob, R. & Shastri, N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419, 480\u2013483 (2002).","journal-title":"Nature"},{"key":"1566_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ni1208","volume":"6","author":"L Saveanu","year":"2005","unstructured":"Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6, 689\u2013697 (2005).","journal-title":"Nat. Immunol."},{"key":"1566_CR18","doi-asserted-by":"publisher","first-page":"e41090","DOI":"10.7554\/eLife.41090","volume":"7","author":"RS Gejman","year":"2018","unstructured":"Gejman, R. S. et al. Rejection of immunogenic tumor clones is limited by clonal fraction. eLife 7, e41090 (2018).","journal-title":"eLife"},{"key":"1566_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S1074-7613(00)80447-1","volume":"6","author":"A Porgador","year":"1997","unstructured":"Porgador, A., Yewdell, J. W., Deng, Y., Bennink, J. R. & Germain, R. N. Localization, quantitation, and in situ detection of specific peptide\u2013MHC class I complexes using a monoclonal antibody. Immunity 6, 715\u2013726 (1997).","journal-title":"Immunity"},{"key":"1566_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coi.2021.02.004","volume":"70","author":"C Thomas","year":"2021","unstructured":"Thomas, C. & Tamp\u00e9, R. MHC I assembly and peptide editing\u2014chaperones, clients, and molecular plasticity in immunity. Curr. Opin. Immunol. 70, 48\u201356 (2021).","journal-title":"Curr. Opin. Immunol."},{"key":"1566_CR21","doi-asserted-by":"publisher","first-page":"D405","DOI":"10.1093\/nar\/gku938","volume":"43","author":"R Vita","year":"2015","unstructured":"Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43, D405\u2013D412 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1566_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.4049\/jimmunol.1901173","volume":"205","author":"A Sachs","year":"2020","unstructured":"Sachs, A. et al. Impact of cysteine residues on MHC binding predictions and recognition by tumor-reactive T cells. J. Immunol. 205, 539\u2013549 (2020).","journal-title":"J. Immunol."},{"key":"1566_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1074\/mcp.M114.042812","volume":"14","author":"M Bassani-Sternberg","year":"2015","unstructured":"Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J. & Mann, M. Mass spectrometry of human leukocyte antigen class i peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell. Proteomics 14, 658\u2013673 (2015).","journal-title":"Mol. Cell. Proteomics"},{"key":"1566_CR24","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2165\/00003088-200847060-00001","volume":"47","author":"GJ Yuen","year":"2008","unstructured":"Yuen, G. J., Weller, S. & Pakes, G. E. A review of the pharmacokinetics of abacavir. Clin. Pharmacokinet. 47, 351\u2013371 (2008).","journal-title":"Clin. Pharmacokinet."},{"key":"1566_CR25","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1073\/pnas.0307067101","volume":"101","author":"AM Martin","year":"2004","unstructured":"Martin, A. M. et al. Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant. Proc. Natl Acad. Sci. USA 101, 4180\u20134185 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1566_CR26","doi-asserted-by":"publisher","first-page":"9959","DOI":"10.1073\/pnas.1207934109","volume":"109","author":"DA Ostrov","year":"2012","unstructured":"Ostrov, D. A. et al. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc. Natl Acad. Sci. USA 109, 9959\u20139964 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1566_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/356443a0","volume":"356","author":"ML Wei","year":"1992","unstructured":"Wei, M. L. & Cresswell, P. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356, 443\u2013446 (1992).","journal-title":"Nature"},{"key":"1566_CR28","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1126\/science.1546329","volume":"255","author":"RA Henderson","year":"1992","unstructured":"Henderson, R. A. et al. HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation. Science 255, 1264\u20131266 (1992).","journal-title":"Science"},{"key":"1566_CR29","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1126\/science.1070925","volume":"296","author":"A Weihofen","year":"2002","unstructured":"Weihofen, A., Binns, K., Lemberg, M. K., Ashman, K. & Martoglio, B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296, 2215\u20132218 (2002).","journal-title":"Science"},{"key":"1566_CR30","first-page":"S15","volume":"9","author":"KH Choo","year":"2008","unstructured":"Choo, K. H. & Ranganathan, S. Flanking signal and mature peptide residues influence signal peptide cleavage. BMC Bioinformatics 9, S15 (2008).","journal-title":"BMC Bioinformatics"},{"key":"1566_CR31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","volume":"9","author":"D Gfeller","year":"2018","unstructured":"Gfeller, D. & Bassani-Sternberg, M. Predicting antigen presentation\u2014what could we learn from a million peptides? Front. Immunol. 9, 1716 (2018).","journal-title":"Front. Immunol."},{"key":"1566_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511\u2013517 (2016).","journal-title":"Bioinformatics"},{"key":"1566_CR33","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12, 1007\u20131017 (2003).","journal-title":"Protein Sci."},{"key":"1566_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S1074-5521(01)00080-1","volume":"8","author":"JL Harris","year":"2001","unstructured":"Harris, J. L., Alper, P. B., Li, J., Rechsteiner, M. & Backes, B. J. Substrate specificity of the human proteasome. Chem. Biol. 8, 1131\u20131141 (2001).","journal-title":"Chem. Biol."},{"key":"1566_CR35","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","volume":"46","author":"JG Abelin","year":"2017","unstructured":"Abelin, J. G. et al. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction. Immunity 46, 315\u2013326 (2017).","journal-title":"Immunity"},{"key":"1566_CR36","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al. Viral and host factors related to the clinical outcome of COVID-19. Nature 583, 437\u2013440 (2020).","DOI":"10.1038\/s41586-020-2355-0"},{"key":"1566_CR37","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"C Rydyznski Moderbacher","year":"2020","unstructured":"Rydyznski Moderbacher, C. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012 (2020).","journal-title":"Cell"},{"key":"1566_CR38","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168 (2020).","journal-title":"Cell"},{"key":"1566_CR39","doi-asserted-by":"publisher","first-page":"eabe4782","DOI":"10.1126\/sciimmunol.abe4782","volume":"6","author":"A Kusnadi","year":"2021","unstructured":"Kusnadi, A. et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells. Sci. Immunol. 6, eabe4782 (2021).","journal-title":"Sci. Immunol."},{"key":"1566_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","volume":"588","author":"T Takahashi","year":"2020","unstructured":"Takahashi, T. et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature 588, 315\u2013320 (2020).","journal-title":"Nature"},{"key":"1566_CR41","doi-asserted-by":"publisher","first-page":"eabg5669","DOI":"10.1126\/sciimmunol.abg5669","volume":"6","author":"V Mallajosyula","year":"2021","unstructured":"Mallajosyula, V. et al. CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients. Sci. Immunol. 6, eabg5669 (2021).","journal-title":"Sci. Immunol."},{"key":"1566_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/pai.13263","volume":"31","author":"A Soresina","year":"2020","unstructured":"Soresina, A. et al. Two X\u2010linked agammaglobulinemia patients develop pneumonia as COVID\u201019 manifestation but recover. Pediatr. Allergy Immunol. 31, 565\u2013569 (2020).","journal-title":"Pediatr. Allergy Immunol."},{"key":"1566_CR43","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.jaip.2020.06.046","volume":"8","author":"E Mira","year":"2020","unstructured":"Mira, E. et al. Rapid recovery of a SARS-CoV-2\u2013infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. J. Allergy Clin. Immunol. Pract. 8, 2793\u20132795 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1566_CR44","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1016\/j.jaip.2020.08.059","volume":"8","author":"H Jin","year":"2020","unstructured":"Jin, H. et al. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma. J. Allergy Clin. Immunol. Pract. 8, 3594\u20133596 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1566_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409\u2013424 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1566_CR46","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1016\/j.cell.2021.05.046","volume":"184","author":"S Weingarten-Gabbay","year":"2021","unstructured":"Weingarten-Gabbay, S. et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell 184, 3962\u20133980.e17 (2021).","journal-title":"Cell"},{"key":"1566_CR47","doi-asserted-by":"publisher","first-page":"8745","DOI":"10.1016\/j.vaccine.2011.07.132","volume":"29","author":"NC Toussaint","year":"2011","unstructured":"Toussaint, N. C., Maman, Y., Kohlbacher, O. & Louzoun, Y. Universal peptide vaccines\u2014optimal peptide vaccine design based on viral sequence conservation. Vaccine 29, 8745\u20138753 (2011).","journal-title":"Vaccine"},{"key":"1566_CR48","doi-asserted-by":"publisher","first-page":"W344","DOI":"10.1093\/nar\/gkw408","volume":"44","author":"H Ashkenazy","year":"2016","unstructured":"Ashkenazy, H. et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 44, W344\u2013W350 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1566_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ijch.201200096","volume":"53","author":"G Celniker","year":"2013","unstructured":"Celniker, G. et al. ConSurf: using evolutionary data to raise testable hypotheses about protein function. Isr. J. Chem. 53, 199\u2013206 (2013).","journal-title":"Isr. J. Chem."},{"key":"1566_CR50","doi-asserted-by":"crossref","unstructured":"Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457\u2013462 (2020).","DOI":"10.1038\/s41586-020-2550-z"},{"key":"1566_CR51","doi-asserted-by":"publisher","first-page":"eabf4063","DOI":"10.1126\/science.abf4063","volume":"371","author":"JM Dan","year":"2021","unstructured":"Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021).","journal-title":"Science"},{"key":"1566_CR52","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.immuni.2020.10.006","volume":"53","author":"AP Ferretti","year":"2020","unstructured":"Ferretti, A. P. et al. Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein. Immunity 53, 1095\u20131107 (2020).","journal-title":"Immunity"},{"key":"1566_CR53","doi-asserted-by":"publisher","first-page":"eabf7550","DOI":"10.1126\/sciimmunol.abf7550","volume":"6","author":"SK Saini","year":"2021","unstructured":"Saini, S. K. et al. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients. Sci. Immunol. 6, eabf7550 (2021).","journal-title":"Sci. Immunol."},{"key":"1566_CR54","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.xcrm.2021.100204","volume":"2","author":"A Tarke","year":"2021","unstructured":"Tarke, A. et al. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Reports Med. 2, 100204 (2021).","journal-title":"Cell Reports Med."},{"key":"1566_CR55","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1073\/pnas.1815239116","volume":"116","author":"NP Croft","year":"2019","unstructured":"Croft, N. P. et al. Most viral peptides displayed by class I MHC on infected cells are immunogenic. Proc. Natl Acad. Sci. USA 116, 3112\u20133117 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1566_CR56","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2015","unstructured":"Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511\u2013517 (2015).","journal-title":"Bioinformatics"},{"key":"1566_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2018.05.014","volume":"7","author":"TJ O\u2019Donnell","year":"2018","unstructured":"O\u2019Donnell, T. J. et al. MHCflurry: open-source class I MHC binding affinity prediction. Cell Syst. 7, 129\u2013132 (2018).","journal-title":"Cell Syst."},{"key":"1566_CR58","doi-asserted-by":"crossref","unstructured":"Scott, D. W. & De Groot, A. S. Can we prevent immunogenicity of human protein drugs? Ann. Rheum. Dis. 69, i72\u2013i76 (2010).","DOI":"10.1136\/ard.2009.117564"},{"key":"1566_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","volume":"152","author":"KC Parker","year":"1994","unstructured":"Parker, K. C., Bednarek, M. A. & Coligan, J. E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152, 163\u2013175 (1994).","journal-title":"J. Immunol."},{"key":"1566_CR60","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1002\/eji.1830260836","volume":"26","author":"A Stryhn","year":"1996","unstructured":"Stryhn, A. et al. Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of binding. Eur. J. Immunol. 26, 1911\u20131918 (1996).","journal-title":"Eur. J. Immunol."},{"key":"1566_CR61","doi-asserted-by":"publisher","first-page":"27979","DOI":"10.1074\/jbc.M114.573402","volume":"289","author":"JA Trujillo","year":"2014","unstructured":"Trujillo, J. A. et al. The cellular redox environment alters antigen presentation. J. Biol. Chem. 289, 27979\u201327991 (2014).","journal-title":"J. Biol. Chem."},{"key":"1566_CR62","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2019.07.009","volume":"178","author":"T Kula","year":"2019","unstructured":"Kula, T. et al. T-Scan: a genome-wide method for the systematic discovery of T cell epitopes. Cell 178, 1016\u20131028 (2019).","journal-title":"Cell"},{"key":"1566_CR63","doi-asserted-by":"crossref","unstructured":"Winter, M. B. et al. Immunoproteasome functions explained by divergence in cleavage specificity and regulation. eLife 6, e27364 (2017).","DOI":"10.7554\/eLife.27364"},{"key":"1566_CR64","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.3389\/fimmu.2018.02463","volume":"9","author":"JA L\u00f3pez de Castro","year":"2018","unstructured":"L\u00f3pez de Castro, J. A. How ERAP1 and ERAP2 shape the peptidomes of disease-associated MHC-I proteins. Front. Immunol. 9, 2463 (2018).","journal-title":"Front. Immunol."},{"key":"1566_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4049\/jimmunol.1300598","volume":"191","author":"E Reeves","year":"2013","unstructured":"Reeves, E., Edwards, C. J., Elliott, T. & James, E. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J. Immunol. 191, 35\u201343 (2013).","journal-title":"J. Immunol."},{"key":"1566_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00251-005-0781-7","volume":"57","author":"M Nielsen","year":"2005","unstructured":"Nielsen, M., Lundegaard, C., Lund, O. & Ke\u015fmir, C. The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57, 33\u201341 (2005).","journal-title":"Immunogenetics"},{"key":"1566_CR67","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-immunol-041015-055254","volume":"35","author":"FM Cruz","year":"2017","unstructured":"Cruz, F. M., Colbert, J. D., Merino, E., Kriegsman, B. A. & Rock, K. L. The biology and underlying mechanisms of cross-presentation of exogenous antigens on MHC-I molecules. Annu. Rev. Immunol. 35, 149\u2013176 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"1566_CR68","doi-asserted-by":"crossref","unstructured":"Guillaume, P. et al. The C-terminal extension landscape of naturally presented HLA-I ligands. Proc. Natl Acad. Sci. USA 115, 5083\u20135088 (2018).","DOI":"10.1073\/pnas.1717277115"},{"key":"1566_CR69","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1074\/jbc.M512263200","volume":"281","author":"Y Samino","year":"2006","unstructured":"Samino, Y. et al. A long N-terminal-extended nested set of abundant and antigenic major histocompatibility complex class I natural ligands from HIV envelope protein. J. Biol. Chem. 281, 6358\u20136365 (2006).","journal-title":"J. Biol. Chem."},{"key":"1566_CR70","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1074\/jbc.M114.607028","volume":"290","author":"C Hassan","year":"2015","unstructured":"Hassan, C. et al. Naturally processed non-canonical HLA-A*02:01 presented peptides. J. Biol. Chem. 290, 2593\u20132603 (2015).","journal-title":"J. Biol. Chem."},{"key":"1566_CR71","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1515\/hsz-2016-0305","volume":"398","author":"TM Josephs","year":"2017","unstructured":"Josephs, T. M., Grant, E. J. & Gras, S. Molecular challenges imposed by MHC-I restricted long epitopes on T cell immunity. Biol. Chem. 398, 1027\u20131036 (2017).","journal-title":"Biol. Chem."},{"key":"1566_CR72","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.1074\/jbc.M117.776542","volume":"292","author":"R SG","year":"2017","unstructured":"SG, R. et al. Unconventional peptide presentation by major histocompatibility complex (MHC) class I allele HLA-A*02:01: breaking confinement. J. Biol. Chem. 292, 5262\u20135270 (2017).","journal-title":"J. Biol. Chem."},{"key":"1566_CR73","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1042\/EBC20180042","volume":"63","author":"AR N\u00f6dling","year":"2019","unstructured":"N\u00f6dling, A. R., Spear, L. A., Williams, T. L., Luk, L. Y. P. & Tsai, Y. H. Using genetically incorporated unnatural amino acids to control protein functions in mammalian cells. Essays Biochem. 63, 237\u2013266 (2019).","journal-title":"Essays Biochem."},{"key":"1566_CR74","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1074\/jbc.M708068200","volume":"283","author":"L Sibilio","year":"2008","unstructured":"Sibilio, L. et al. A single bottleneck in HLA-C assembly. J. Biol. Chem. 283, 1267\u20131274 (2008).","journal-title":"J. Biol. Chem."},{"key":"1566_CR75","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/s41551-019-0431-2","volume":"3","author":"AM Moreno","year":"2019","unstructured":"Moreno, A. M. et al. Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy. Nat. Biomed. Eng. 3, 806\u2013816 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"1566_CR76","doi-asserted-by":"publisher","first-page":"e1577127","DOI":"10.1080\/2162402X.2019.1577127","volume":"8","author":"R Ajina","year":"2019","unstructured":"Ajina, R. et al. SpCas9-expression by tumor cells can cause T cell-dependent tumor rejection in immunocompetent mice. Oncoimmunology 8, e1577127 (2019).","journal-title":"Oncoimmunology"},{"key":"1566_CR77","doi-asserted-by":"crossref","first-page":"842141","DOI":"10.1155\/2012\/842141","volume":"2012","author":"MA Ayala Garc\u00eda","year":"2012","unstructured":"Ayala Garc\u00eda, M. A., Gonz\u00e1lez Yebra, B., L\u00f3pez Flores, A. L. & Guan\u00ed Guerra, E. The major histocompatibility complex in transplantation. J. Transplant. 2012, 842141 (2012).","journal-title":"J. Transplant."},{"key":"1566_CR78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/cpt.2343","volume":"110","author":"P Deshpande","year":"2021","unstructured":"Deshpande, P. et al. Immunopharmacogenomics: mechanisms of HLA-associated drug reactions. Clin. Pharmacol. Ther. 110, 607\u2013615 (2021).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1566_CR79","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.immuni.2006.09.005","volume":"25","author":"JW Yewdell","year":"2006","unstructured":"Yewdell, J. W. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25, 533\u2013543 (2006).","journal-title":"Immunity"},{"key":"1566_CR80","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2018.00276","volume":"9","author":"E Panagioti","year":"2018","unstructured":"Panagioti, E., Klenerman, P., Lee, L. N., van der Burg, S. H. & Arens, R. Features of effective T cell-inducing vaccines against chronic viral infections. Front. Immunol. 9, 276 (2018).","journal-title":"Front. Immunol."},{"key":"1566_CR81","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nri.2017.131","volume":"18","author":"Z Hu","year":"2018","unstructured":"Hu, Z., Ott, P. A. & Wu, C. J. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168\u2013182 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1566_CR82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet.journal 17, 10 (2011).","journal-title":"EMBnet.journal"},{"key":"1566_CR83","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"1566_CR84","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/1471-2105-10-394","volume":"10","author":"Y Kim","year":"2009","unstructured":"Kim, Y., Sidney, J., Pinilla, C., Sette, A. & Peters, B. Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior. BMC Bioinformatics 10, 394 (2009).","journal-title":"BMC Bioinformatics"},{"key":"1566_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-6-7","volume":"6","author":"RD Bremel","year":"2010","unstructured":"Bremel, R. D. & Homan, E. J. An integrated approach to epitope analysis I: dimensional reduction, visualization and prediction of MHC binding using amino acid principal components and regression approaches. Immunome Res. 6, 7 (2010).","journal-title":"Immunome Res."},{"key":"1566_CR86","doi-asserted-by":"crossref","unstructured":"Ashkenazy, H., Erez, E., Martz, E., Pupko, T. & Ben-Tal, N. ConSurf 2010: calculating evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic Acids Res. 38, W529\u2013W533 (2010).","DOI":"10.1093\/nar\/gkq399"},{"key":"1566_CR87","doi-asserted-by":"publisher","first-page":"W281","DOI":"10.1093\/nar\/gks469","volume":"40","author":"MCF Thomsen","year":"2012","unstructured":"Thomsen, M. C. F. & Nielsen, M. Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion. Nucleic Acids Res. 40, W281\u2013W287 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1566_CR88","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1566_CR89","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","volume":"11","author":"TJ O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell, T. J., Rubinsteyn, A. & Laserson, U. MHCflurry 2.0: Improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing. Cell Syst. 11, 42\u201348 (2020).","journal-title":"Cell Syst."},{"key":"1566_CR90","doi-asserted-by":"publisher","first-page":"3705","DOI":"10.4049\/jimmunol.1800914","volume":"201","author":"D Gfeller","year":"2018","unstructured":"Gfeller, D. et al. The length distribution and multiple specificity of naturally presented HLA-I ligands. J. Immunol. 201, 3705\u20133716 (2018).","journal-title":"J. Immunol."},{"key":"1566_CR91","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"1566_CR92","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1566_CR93","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1128\/JVI.01621-10","volume":"85","author":"MC Verweij","year":"2011","unstructured":"Verweij, M. C. et al. The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus. J. Virol. 85, 2351\u20132363 (2011).","journal-title":"J. Virol."},{"key":"1566_CR94","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/JVI.06197-11","volume":"86","author":"H Byun","year":"2012","unstructured":"Byun, H. et al. Requirements for mouse mammary tumor virus Rem signal peptide processing and function. J. Virol. 86, 214\u2013225 (2012).","journal-title":"J. Virol."},{"key":"1566_CR95","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/bit.24776","volume":"110","author":"L Kober","year":"2013","unstructured":"Kober, L., Zehe, C. & Bode, J. Optimized signal peptides for the development of high expressing CHO cell lines. Biotechnol. Bioeng. 110, 1164\u20131173 (2013).","journal-title":"Biotechnol. Bioeng."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01566-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01566-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T17:48:01Z","timestamp":1701625681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-022-01566-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":95,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["1566"],"URL":"https:\/\/doi.org\/10.1038\/s41587-022-01566-x","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"1 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.J.E. is a founder of T-Scan Therapeutics, MAZE Therapeutics, ImmuneID and Mirimus, serves on the scientific advisory boards of Homology Medicines, ImmuneID, MAZE Therapeutics and T-Scan Therapeutics and is an advisor for MPM Capital, none of which affect this work. P.M.B. and S.J.E. are inventors of and have submitted a patent on the EpiScan technology. The remaining authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}